Technology takes on breast cancer

Technology takes on breast cancer

(Medical Xpress)—An ANU student has developed a smartphone app for the early detection of breast cancer.

Software engineering undergraduate Sanjay Sreekumar designed the app for organisation The Young Adults Program.

"There's a big potential for apps to provide a proactive means of detecting illnesses," Mr Sreekumar said.

"This is not something that just targets specific people. It can affect everyone regardless of age and gender."

"I always feel sympathetic when I hear stories about people suffering from cancer. This is something I can do."

The YAP app is designed to allow individuals to self-monitor for early signs of breast cancer. By providing monthly inputs of breast irregularities, the application can help identify if further is required.

Mr Sreekumar is currently working on improving the app by adding visual aids and multiple languages. He wants to get the word out to organisations and promote the app internationally.

Following the success of this app he hopes to extend his skills to other health areas.

"The core of YAP is providing an additional means of examination to save lives," he said.

"It could apply to many illnesses. I want to see this technology being used world-wide."

add to favorites email to friend print save as pdf

Related Stories

New smartphone application improves colonoscopy preparation

May 19, 2013

The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...

Recommended for you

Scientists discover hidden subpopulation of melanoma cells

3 hours ago

UNC School of Medicine researchers have pinpointed a set of intriguing characteristics in a previously unknown subpopulation of melanoma cancer cells in blood vessels of tumors. These cells, which mimic non-cancerous ...

Blood biomarker may detect lung cancer

21 hours ago

A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer. The study abstract ...

User comments